Regeneration of the Immune System after Radiation Exposure

辐射暴露后免疫系统的再生

基本信息

  • 批准号:
    10686385
  • 负责人:
  • 金额:
    $ 68.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-08-18 至 2027-06-30
  • 项目状态:
    未结题

项目摘要

Abstract Radiation-Induced Immune Dysfunction (RIID) is a critical component of both acute and delayed effects of radiation exposure, which causes a multi-organ failure (MOF) syndrome, operationally divided based upon timing of clinical manifestations, as acute radiation syndrome (ARS) and delayed effects of acute radiation exposure (DEARE). The immediate lethality of ARS is caused by bone marrow and intestinal failure, with subsequent neutropenia, anemia, thrombocytopenia, lymphopenia, and loss of intestinal epithelial barrier, resulting in bacteremia, septic shock, and systemic inflammatory response. To date, FDA-approved radiation countermeasures are hematopoietic growth factors, such as, G-CSF, GM-CSF and Romiplostim that promote myeloid regeneration in the marrow. Ionizing radiation (IR) can cause reversible and irreversible damage to the immune system. Atomic bomb (A-bomb) survivors from Japan exhibited reduction in T helper cell subsets, alterations in naïve and memory T and B lymphocyte numbers and function, increased levels of serum pro- inflammatory cytokines, indicating significant residual injury and impairment of lymphocyte homeostasis in the lymphoid organs. We will investigate the immune landscape of regeneration in bone marrow, peripheral lymphoid organs (spleen, thymus, and peritoneal lymph nodes) and mucosa-associated lymphoid tissue (MALT) of the intestine and lungs, determine the functionality of antigen presenting cells, and whether IR induces mitochondrial dysfunction, inhibits macro- and chaperone-mediated autophagy, and accelerates T cell immunosenescence and inflammation following WBI under aim 1. We will also examine the regeneration of immune effector cells for mitochondrial dysfunction, inhibition of autophagy, accelerated immunosenescence, T cell exhaustion and inflammation in lymphocytes from peripheral lymphoid organs in mice exposed to IR and treated with radio-mitigators, TPOm or Flt3L or G-CSF (as control), 1-day post-WBI in aim 2. Under aim 3 we will develop an immuno-conditioning regimen to restore functional immune deficit for immunization protocols in radiation survivors, treated with or without radio-mitigators. We will also examine the effects of metformin and p38/MAPK inhibitor to overcome T cell immunosenescence as conditioning regimens with immunological outcomes measured by antigen-specific IgM, IgG and Th1 and Th2 responses. Relevance. Our proposal will define the functional radio-immunobiology of the regenerative immune system after WBI in mice. Since the tissue targets of radiation injury are well studied, we can also correlate whether T cell immunosenescence and dysfunction of myeloid population contributes to DEARE. These studies will provide a blueprint for developing optimized immuno-conditioning regimens for immunization protocols in radiation survivors that can be extended to immunocompromised and elderly population.
抽象的 辐射诱导的免疫功能障碍(RIID)是急性和延迟作用的关键成分 导致多器官故障(MOF)综合征的辐射暴露在操作上根据时间分裂 临床表现,作为急性辐射综合征(ARS)和急性辐射暴露的延迟作用 (亲爱的)。 ARS的直接致死性是由骨髓和肠道衰竭引起的,随后 中性粒细胞减少,贫血,血小板减少症,淋巴细胞减少症和肠上皮屏障的丧失,导致 菌血症,败血性休克和全身性炎症反应。迄今为止,FDA批准的辐射 对策是造血生长因素,例如G-CSF,GM-CSF和Romiplostim 骨髓中的髓样再生。电离辐射(IR)可能会对 免疫系统。来自日本的原子弹(A-BOMB)表面暴露于T辅助细胞子集的减少, 天真和记忆T和B淋巴细胞的数量和功能的改变,血清疗法水平提高 炎性细胞因子,表明严重的残留损伤和淋巴细胞稳态损害 淋巴器官。 我们将研究骨髓再生的免疫景观,外周淋巴器官(脾脏,, 胸腺和肺淋巴结淋巴结淋巴结和腹膜淋巴结淋巴结(麦芽)和肺的淋巴组织(麦芽), 确定抗原呈现细胞的功能,以及IR是否诱导线粒体功能障碍,抑制 宏观和伴侣介导的自噬,并加速T细胞免疫和注射 在AIM 1下进行WBI。我们还将检查线粒体免疫效应细胞的再生 功能障碍,抑制自噬,加速免疫,T细胞耗尽和炎症 暴露于IR的小鼠外周淋巴器官的淋巴细胞,并用射频降低剂,TPOM或 FLT3L或G-CSF(作为对照),AIM 2中的1天后。在AIM 3下,我们将开发免疫条件 恢复用于辐射存活中免疫方案的功能免疫防御方案,并用或 没有无线电降低器。我们还将检查二甲双胍和p38/MAPK抑制剂的影响 细胞免疫吸收作为条件方案,具有免疫结局,以抗原特异性测量 IgM,IgG和Th1和Th2响应。 关联。我们的建议将定义再生免疫系统的功能无线电生物学 WBI在小鼠中。由于辐射损伤的组织靶标很好地研究了,我们还可以相关 髓样群体的细胞免疫和功能障碍有助于Deare。这些研究将提供 用于开发优化的免疫条件方案的蓝图,用于辐射中的免疫条件方案 可以扩展到免疫功能低下和老年人口的幸存者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Chandan Guha的其他基金

Understanding stem cell heterogeneity and niche function in intestinal regeneration after irradiation
了解辐射后肠道再生中的干细胞异质性和生态位功能
  • 批准号:
    10910625
    10910625
  • 财政年份:
    2023
  • 资助金额:
    $ 68.23万
    $ 68.23万
  • 项目类别:
Regeneration of the Immune System after Radiation Exposure
辐射暴露后免疫系统的再生
  • 批准号:
    10474871
    10474871
  • 财政年份:
    2022
  • 资助金额:
    $ 68.23万
    $ 68.23万
  • 项目类别:
Relative Immunological Effectiveness (RIE) of Carbon Ion Radiation Therapy for Pancreatic Cancer
碳离子放射治疗胰腺癌的相对免疫有效性(RIE)
  • 批准号:
    10158123
    10158123
  • 财政年份:
    2021
  • 资助金额:
    $ 68.23万
    $ 68.23万
  • 项目类别:
Relative Immunological Effectiveness (RIE) of Carbon Ion Radiation Therapy for Pancreatic Cancer
碳离子放射治疗胰腺癌的相对免疫有效性(RIE)
  • 批准号:
    10330035
    10330035
  • 财政年份:
    2021
  • 资助金额:
    $ 68.23万
    $ 68.23万
  • 项目类别:
Relative Immunological Effectiveness (RIE) of Carbon Ion Radiation Therapy for Pancreatic Cancer
碳离子放射治疗胰腺癌的相对免疫有效性(RIE)
  • 批准号:
    10544737
    10544737
  • 财政年份:
    2021
  • 资助金额:
    $ 68.23万
    $ 68.23万
  • 项目类别:
Stromal cell therapy as a treatment against Gastrointestinal Acute Radiation Syndrome (GI-ARS)
基质细胞疗法作为胃肠道急性放射综合症(GI-ARS)的治疗方法
  • 批准号:
    9886178
    9886178
  • 财政年份:
    2018
  • 资助金额:
    $ 68.23万
    $ 68.23万
  • 项目类别:
Stromal cell therapy as a treatment against Gastrointestinal Acute Radiation Syndrome (GI-ARS)
基质细胞疗法作为胃肠道急性放射综合症(GI-ARS)的治疗方法
  • 批准号:
    10359772
    10359772
  • 财政年份:
    2018
  • 资助金额:
    $ 68.23万
    $ 68.23万
  • 项目类别:
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
使用聚焦超声增加黑色素瘤免疫原性并抑制肿瘤诱导的 T 细胞耐受
  • 批准号:
    10365967
    10365967
  • 财政年份:
    2018
  • 资助金额:
    $ 68.23万
    $ 68.23万
  • 项目类别:
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
使用聚焦超声增加黑色素瘤免疫原性并抑制肿瘤诱导的 T 细胞耐受
  • 批准号:
    9893711
    9893711
  • 财政年份:
    2018
  • 资助金额:
    $ 68.23万
    $ 68.23万
  • 项目类别:
Immune modulation of radiation therapy with Flt3 ligand
Flt3配体对放射治疗的免疫调节
  • 批准号:
    9129622
    9129622
  • 财政年份:
    2015
  • 资助金额:
    $ 68.23万
    $ 68.23万
  • 项目类别:

相似国自然基金

线粒体ClpP激动剂通过铁死亡-免疫调控cross-talk治疗急性髓细胞白血病的机制研究
  • 批准号:
    82370171
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
基于FACS的AT1R偏向性激动剂的超高通量筛选
  • 批准号:
    31600628
  • 批准年份:
    2016
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目
PPAR-α激动剂在急性心肌梗死中调控巨噬细胞极化促进血管生成的机制研究
  • 批准号:
    81500267
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
应用芳香羟受体激动剂FICZ预防小鼠急性移植物抗宿主病的机制研究
  • 批准号:
    81500151
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
共生表皮葡萄球菌预防糖尿病伤口细胞内感染
  • 批准号:
    10679628
    10679628
  • 财政年份:
    2023
  • 资助金额:
    $ 68.23万
    $ 68.23万
  • 项目类别:
Stabilizing the tripartite synaptic complex following TBI
TBI 后稳定三方突触复合体
  • 批准号:
    10844877
    10844877
  • 财政年份:
    2023
  • 资助金额:
    $ 68.23万
    $ 68.23万
  • 项目类别:
Role of the microglial immune-oxysterol 25-hydroxycholesterol in mediating neuroinflammation and neurodegeneration in the P301S tau transgenic mouse model of Alzheimer's disease
小胶质细胞免疫-氧甾醇25-羟基胆固醇在阿尔茨海默病P301S tau转基因小鼠模型中介导神经炎症和神经变性中的作用
  • 批准号:
    10645467
    10645467
  • 财政年份:
    2023
  • 资助金额:
    $ 68.23万
    $ 68.23万
  • 项目类别:
A Human Laboratory Study of Exenatide for Reducing the Reinforcing Effects of Cocaine
艾塞那肽减少可卡因增强作用的人体实验室研究
  • 批准号:
    10573011
    10573011
  • 财政年份:
    2023
  • 资助金额:
    $ 68.23万
    $ 68.23万
  • 项目类别:
The Impact of Surgery on Outcomes for Patients taking Medications for Opioid Use Disorder
手术对服用阿片类药物使用障碍患者的结果的影响
  • 批准号:
    10793072
    10793072
  • 财政年份:
    2023
  • 资助金额:
    $ 68.23万
    $ 68.23万
  • 项目类别: